These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16862321)

  • 21. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Otaguiri KK; Dos Santos DF; Slavov SN; Depieri LV; Palma PVB; Meirelles FV; Covas DT; da Silveira JC; Kashima S
    AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1075-1082. PubMed ID: 30229663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals.
    Sabouri AH; Saito M; Usuku K; Bajestan SN; Mahmoudi M; Forughipour M; Sabouri Z; Abbaspour Z; Goharjoo ME; Khayami E; Hasani A; Izumo S; Arimura K; Farid R; Osame M
    J Gen Virol; 2005 Mar; 86(Pt 3):773-781. PubMed ID: 15722539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins.
    Nakane S; Shirabe S; Moriuchi R; Mizokami A; Furuya T; Nishiura Y; Okazaki S; Yoshizuka N; Suzuki Y; Nakamura T; Katamine S; Gojobori T; Eguchi K
    J Neurovirol; 2000 Aug; 6(4):275-83. PubMed ID: 10951551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
    Renjifo B; Chou K; Soto Ramirez L; Garcia Vallejo F; Essex M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S146-53. PubMed ID: 8797717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Suzuki J; Kira J; Baba E; Nakamura M; Koyanagi Y; Nakamura T; Kawano Y; Yamasaki K; Shirabe S; Hatano N; Hayashi K; Yamamoto N; Kobayashi T
    J Infect Dis; 1996 May; 173(5):1115-22. PubMed ID: 8627062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
    Alberti C; Cartier L; Valenzuela MA; Puente J; Tanaka Y; Ramirez E
    J Med Virol; 2011 Sep; 83(9):1641-9. PubMed ID: 21739457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs.
    Kubota R; Hanada K; Furukawa Y; Arimura K; Osame M; Gojobori T; Izumo S
    J Immunol; 2007 May; 178(9):5966-72. PubMed ID: 17442981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
    Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
    BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
    J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth.
    Quintremil S; Alberti C; Rivera M; Medina F; Puente J; Cartier L; Ramírez E; Tanaka Y; Valenzuela MA
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):68-79. PubMed ID: 26389656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in São Paulo, Brazil.
    Domingues RB; Muniz MR; Pinho JR; Bassit L; Jorge ML; Alquezar AS; Marchiori PE; Chamone DF; Scaff M
    Clin Infect Dis; 1995 Jun; 20(6):1540-2. PubMed ID: 7548506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.